Should You Add Calithera Biosciences Inc (CALA) Stock to Your Portfolio Wednesday?

Wednesday, January 11, 2023 11:39 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Calithera Biosciences Inc (CALA) Stock to Your Portfolio Wednesday?

Calithera Biosciences Inc (CALA) is around the bottom of the Healthcare sector according to InvestorsObserver. CALA received an overall rating of 0, which means that it scores higher than 0% of stocks. Additionally, Calithera Biosciences Inc scored a 23 in the Healthcare sector, ranking it higher than 23% of stocks in that sector.

CALA has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on CALA!

See Full CALA Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 0 would rank higher than 0 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Calithera Biosciences Inc Stock Today?

Calithera Biosciences Inc (CALA) stock is trading at $0.53 as of 11:38 AM on Wednesday, Jan 11, a rise of $0.05, or 10.63% from the previous closing price of $0.48. The stock has traded between $0.49 and $0.57 so far today. Volume today is above average. So far 676,920 shares have traded compared to average volume of 329,480 shares. Click Here to get the full Stock Report for Calithera Biosciences Inc stock.